Dan Teleman

Dan Teleman

No más puestos en curso

Fortuna: 113 268 $ al 30/09/2026

Health Technology
Consumer Services
Government

Perfil

Dan Teleman was the founder of PRF Technologies Ltd., founded in 2007, and served as Chief Executive Officer from 2007 to 2010.
Former jobs include Chief Executive Officer at Atox Bio Ltd. from 2011 to 2022, Chief Executive Officer at Pharma Two B Ltd. from 2023 to 2025, Chief Executive Officer & Director at Nasus Pharma Ltd. from 2025 to 2026, Chairman at Tamarix Pharma Ltd from 2021 to 2023, Head-Marketing & Sales at Amgen, Inc., Senior Business Development Officer at W World Corp., Principal at Israel Defense Forces, and Executive Partner at Israel Biotech Fund from 2022 to 2023.
Education includes graduate studies at Ben-Gurion University of the Negev and an MBA from The Fuqua School of Business.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
17/06/2026 30.696 ( 0,26 % ) 113 268 $ 30/09/2026

Antiguos cargos conocidos de Dan Teleman.

EmpresasCargoFin
NASUS PHARMA LTD. Director Ejecutivo 22/07/2026
Director Ejecutivo 01/01/2025
Inversor de Capital Privado 01/05/2023
Presidente 01/05/2023
Director Ejecutivo 01/05/2022
Ver el detalle de la experiencia de Dan Teleman.

Formación de Dan Teleman.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

14

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Consumer Services

Government

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology